Presage Biosciences raises $13M and inks new deal with Merck for cancer drug tests New funds, new partners: Seattle’s Presage Biosciences announced $13 million in funding as well new collaborations with biotech giant Merck… Read More
Presage Biosciences raises $6M for technology to test new cancer drugs, appoints new CEO Cancer technology maker Presage Biosciences has raised $6 million and appointed a new CEO as it moves to support the… Read More
